CVS P/E Ratio Analysis

A P/E ratio of 27.0x means investors pay $27 for every $1 of the company's annual earnings per share, so a higher figure signals a richer valuation relative to profits.

That level sits above the sector median of 23.3x, placing CVS in the 58th percentile among peers — meaning it is more expensive than 58% of comparable companies. The trend data is N/A: the year-over-year change is N/A and the quarter-over-quarter change is N/A, so no direction can be established from this metric alone. The combination of a valuation above the median with no observable trend leaves little clarity; the multiple is not extreme, but it offers no momentum signal to justify chasing the stock. This creates moderate risk if earnings disappoint, since the price already embeds a premium to the sector. The metric supports the overall CAUTIOUS verdict because the elevated P/E lacks supporting trend evidence, making the stock less attractive on a relative value basis.

Frequently Asked Questions